Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pineros M, Znaor A, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149:778–89.

Article  CAS  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Milella M, Rutigliano M, Lasorsa F, Ferro M, Bianchi R, Fallara G, et al. The role of MUC1 in renal cell carcinoma. Biomolecules. 2024;14:315.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Linehan WM, Ricketts CJ. The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications. Nat Rev Urol. 2019;16:539–52.

Article  CAS  PubMed  Google Scholar 

Cairns P. Renal cell carcinoma. Cancer Biomark. 2010;9:461–73.

Article  PubMed  Google Scholar 

Lasorsa F, Rutigliano M, Milella M, Ferro M, Pandolfo SD, Crocetto F, et al. Cellular and Molecular players in the tumor microenvironment of renal cell carcinoma. J Clin Med. 2023;12:3888.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Netti GS, Lucarelli G, Spadaccino F, Castellano G, Gigante M, Divella C, et al. PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma. Aging. 2020;12:7585–602.

Article  PubMed  PubMed Central  Google Scholar 

Lucarelli G, Rutigliano M, Ferro M, Giglio A, Intini A, Triggiano F, et al. Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma. Urol Oncol. 2017;35:461-e15- e27.

Article  Google Scholar 

Lasorsa F, Rutigliano M, Milella M, Ferro M, Pandolfo SD, Crocetto F, et al. Complement system and the kidney: its role in renal diseases, kidney transplantation and renal cell carcinoma. Int J Mol Sci. 2023;24:16515.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghini V, Laera L, Fantechi B, Monte FD, Benelli M, McCartney A, et al. Metabolomics to assess response to immune checkpoint inhibitors in patients with non-small-cell lung cancer. Cancers  2020;12:13574.

Google Scholar 

Lasorsa F, di Meo NA, Rutigliano M, Milella M, Ferro M, Pandolfo SD, et al. Immune checkpoint inhibitors in renal cell carcinoma: molecular basis and rationale for their use in clinical practice. Biomedicines. 2023;11:1071.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo Y, Shen D, Chen L, Wang G, Liu X, Qian K, et al. Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma. Aging. 2019;11:6029–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu WH, Xu Y, Wang J, Wan FN, Wang HK, Cao DL, et al. Prognostic value and immune infiltration of novel signatures in clear cell renal cell carcinoma microenvironment. Aging. 2019;11:6999–7020.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wolf MM, Kimryn Rathmell W, Beckermann KE. Modeling clear cell renal cell carcinoma and therapeutic implications. Oncogene. 2020;39:3413–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao J, Subramanian C, Rock CO, Jackowski S. Human pantothenate kinase 4 is a pseudo-pantothenate kinase. Protein Sci. 2019;28:1031–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dansie LE, Reeves S, Miller K, Zano SP, Frank M, Pate C, et al. Physiological roles of the pantothenate kinases. Biochem Soc Trans. 2014;42:1033–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iacobas DA, Tuli NY, Iacobas S, Rasamny JK, Moscatello A, Geliebter J, et al. Gene master regulators of papillary and anaplastic thyroid cancers. Oncotarget. 2018;9:2410–24.

Article  PubMed  Google Scholar 

Liu Y, Cheng Z, Li Q, Pang Y, Cui L, Qian T, et al. Prognostic significance of the PANK family expression in acute myeloid leukemia. Ann Transl Med. 2019;7:261.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Audam TN, Howard CM, Garrett LF, Zheng YW, Bradley JA, Brittian KR, et al. Cardiac PANK1 deletion exacerbates ventricular dysfunction during pressure overload. Am J Physiol Heart Circ Physiol. 2021;321:H784–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leonardi R, Rock CO, Jackowski S. Pank1 deletion in leptin-deficient mice reduces hyperglycaemia and hyperinsulinaemia and modifies global metabolism without affecting insulin resistance. Diabetologia. 2014;57:1466–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang L, Zhang B, Wang X, Liu Z, Li J, Zhang S, et al. P53/PANK1/miR-107 signalling pathway spans the gap between metabolic reprogramming and insulin resistance induced by high-fat diet. J Cell Mol Med. 2020;24:3611–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kluth M, Galal R, Krohn A, Weischenfeldt J, Tsourlakis C, Paustian L, et al. Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer. Int J Oncol. 2015;46:1637–42.

Article  CAS  PubMed  Google Scholar 

Kfir-Erenfeld S, Haggiag N, Biton M, Stepensky P, Assayag-Asherie N, Yefenof E. miR-103 inhibits proliferation and sensitizes hemopoietic tumor cells for glucocorticoid-induced apoptosis. Oncotarget. 2017;8:472–89.

Article  PubMed  Google Scholar 

Song N, Ma X, Li H, Zhang Y, Wang X, Zhou P, et al. microRNA-107 functions as a candidate tumor suppressor gene in renal clear cell carcinoma involving multiple genes. Urol Oncol. 2015;33:e2051–11.

Article  Google Scholar 

Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, et al. UALCAN: a portal for facilitating Tumor Subgroup Gene expression and survival analyses. Neoplasia. 2017;19:649–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98–102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46:D956–63.

Article  CAS  PubMed  Google Scholar 

Vuong L, Kotecha RR, Voss MH, Hakimi AA. Tumor Microenvironment dynamics in Clear-Cell Renal Cell Carcinoma. Cancer Discov. 2019;9:1349–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tamma R, Rutigliano M, Lucarelli G, Annese T, Ruggieri S, Cascardi E, et al. Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment. Urol Oncol. 2019;37:355-e11- e19.

Article  Google Scholar 

Lucarelli G, Netti GS, Rutigliano M, Lasorsa F, Loizzo D, Milella M, et al. MUC1 expression affects the immunoflogosis in renal cell carcinoma microenvironment through complement system activation and immune infiltrate modulation. Int J Mol Sci. 2023;24:4814.

Article  CAS  PubMed  PubMed Central